Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01247324
Brief Title: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

First Submitted : November 23, 2010
First Submitted that Met QC Criteria : November 23, 2010
First Posted : November 24, 2010 (Estimate)

Results First Submitted : March 30, 2017
Results First Submitted that Met QC Criteria : July 17, 2017
Results First Posted : July 18, 2017

Certification/Extension First Submitted : October 10, 2016
Certification/Extension First Submitted that Met QC Criteria : October 10, 2016
Certification/Extension First Posted : October 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 15, 2020
Last Update Posted : December 17, 2020